Global Pain Management Market Report: 2012 Edition
As the technological environment is swiftly undergoing evolution, companies operating in the healthcare/science/pharmaceutical/therapeutic industry are now scaling new heights. Also, the respective sector’s growth is boosted by the rising number of health related issues emanating from the changing lifestyle and incessantly evolving surroundings. To address the rising demand for better healthcare options and the unmet needs within the some of the underlying segments, related companies are coming up with novel and improved therapies some of which fall within the bounds of pain management therapeutics.
Pain management market is one of the emerging fields within the pharmaceutical industry. Pain is one of the key associated symptoms in various medical conditions, and can potentially interpose with one’s quality of life and day-to-day working schedule. Three major variants of pain include nociceptive, neuropathic and inflammatory, while the duration can vary from acute to chronic. Furthermore, for placating various painful conditions different treatment regimes are followed, and the most commonly used drug classes for alleviating pain include local analgesics, NSAIDs and opioids.
This report provides a comprehensive overview of the global market covering various geographic regions. The pain management realm is intensely competitive with numerous global and domestic corporations holding the reins of the same. The leading industry players include Pfizer, Eli Lilly, Novartis and J&J. In addition to the industry competition, product contention is also intense as numerous innovative, novel and highly effective therapeutic variants are available in the market. Furthermore, market dynamics viz., key trends and industry developments, growth drivers and the challenges faced by the industry are discussed in detail.
Pain management market is one of the emerging fields within the pharmaceutical industry. Pain is one of the key associated symptoms in various medical conditions, and can potentially interpose with one’s quality of life and day-to-day working schedule. Three major variants of pain include nociceptive, neuropathic and inflammatory, while the duration can vary from acute to chronic. Furthermore, for placating various painful conditions different treatment regimes are followed, and the most commonly used drug classes for alleviating pain include local analgesics, NSAIDs and opioids.
This report provides a comprehensive overview of the global market covering various geographic regions. The pain management realm is intensely competitive with numerous global and domestic corporations holding the reins of the same. The leading industry players include Pfizer, Eli Lilly, Novartis and J&J. In addition to the industry competition, product contention is also intense as numerous innovative, novel and highly effective therapeutic variants are available in the market. Furthermore, market dynamics viz., key trends and industry developments, growth drivers and the challenges faced by the industry are discussed in detail.
1. PAIN MANAGEMENT
1.1 Classification of Pain
1.1.1 Pain Intensity and Duration
1.2 Pain Treatment
1.2.1 Pain Management Therapeutics
1.2.2 Pain Management Regime
2. PAIN MANAGEMENT - MARKET SIZE
2.1 Global Pain Management Market
Market Value
Regional Breakdown
2.2 Pain Management Market by Geography
2.2.1 The US Pain Management Market
US Opioid Market
Acute Pain Market Share
Chronic Pain Market Share
2.2.2 China’s Pain Management Market
NSAID
Market Size
Market Share
Steroid
Market Size
Market Share
2.2.3 Italy’s Pain Management Market
Market Value
Market Volume
Market Share
By Revenue
By Units
2.2.4 India’s Pain Management Market
3. MARKET DYNAMICS
3.1 Key Trends & Industry developments
3.1.1 NEKTAR’s Novel Therapeutic Formulations
3.1.2 Pain Management Therapeutics under Phase II Development
3.1.3 R&D Pipeline Expansion by MOXDUO and Nuvo
3.1.4 Clinical Trial of ARX-01
3.2 Growth Drivers
3.2.1 Higher Spending on Medicines
3.2.2 Launch of NMEs (New Molecular Entities)
3.2.3 Rising Demand for Better Healthcare Options
3.2.4 Growing Ageing Population
3.2.5 Rising Healthcare Expenditure
3.2.6 Increasing Global GNI (Gross National Income)
3.3 Challenges
3.3.1 Sluggish Pace of Innovation
3.3.2 Abusive Uses of Therapeutic Drugs
3.3.3 Escalating Price Pressure
4. COMPETITIVE LANDSCAPE
4.1 Industry Competition
4.2 Product Competition
4.2.1 Product Comparison
5. COMPANY PROFILES
5.1 Pfizer, Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Focus on Growth
Strategic Acquisitions
5.2 Eli Lilly and Company
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
Focus on Devising Novel Therapeutic Molecules
Capacity Expansion
5.3 Novartis AG
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
Extending Leadership in Innovation
Driving Productivity of Organization
5.4 Johnson & Johnson
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
Focus on Financial Risk Minimization
Concentration on Long-term Growth
6. PAIN MANAGEMENT MARKET OUTLOOK
The US Anti-Inflammatory Biologics Market Outlook
Outside US Anti-inflammatory Biologics Market Outlook
1.1 Classification of Pain
1.1.1 Pain Intensity and Duration
1.2 Pain Treatment
1.2.1 Pain Management Therapeutics
1.2.2 Pain Management Regime
2. PAIN MANAGEMENT - MARKET SIZE
2.1 Global Pain Management Market
Market Value
Regional Breakdown
2.2 Pain Management Market by Geography
2.2.1 The US Pain Management Market
US Opioid Market
Acute Pain Market Share
Chronic Pain Market Share
2.2.2 China’s Pain Management Market
NSAID
Market Size
Market Share
Steroid
Market Size
Market Share
2.2.3 Italy’s Pain Management Market
Market Value
Market Volume
Market Share
By Revenue
By Units
2.2.4 India’s Pain Management Market
3. MARKET DYNAMICS
3.1 Key Trends & Industry developments
3.1.1 NEKTAR’s Novel Therapeutic Formulations
3.1.2 Pain Management Therapeutics under Phase II Development
3.1.3 R&D Pipeline Expansion by MOXDUO and Nuvo
3.1.4 Clinical Trial of ARX-01
3.2 Growth Drivers
3.2.1 Higher Spending on Medicines
3.2.2 Launch of NMEs (New Molecular Entities)
3.2.3 Rising Demand for Better Healthcare Options
3.2.4 Growing Ageing Population
3.2.5 Rising Healthcare Expenditure
3.2.6 Increasing Global GNI (Gross National Income)
3.3 Challenges
3.3.1 Sluggish Pace of Innovation
3.3.2 Abusive Uses of Therapeutic Drugs
3.3.3 Escalating Price Pressure
4. COMPETITIVE LANDSCAPE
4.1 Industry Competition
4.2 Product Competition
4.2.1 Product Comparison
5. COMPANY PROFILES
5.1 Pfizer, Inc.
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Focus on Growth
Strategic Acquisitions
5.2 Eli Lilly and Company
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
Focus on Devising Novel Therapeutic Molecules
Capacity Expansion
5.3 Novartis AG
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
Extending Leadership in Innovation
Driving Productivity of Organization
5.4 Johnson & Johnson
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
Focus on Financial Risk Minimization
Concentration on Long-term Growth
6. PAIN MANAGEMENT MARKET OUTLOOK
The US Anti-Inflammatory Biologics Market Outlook
Outside US Anti-inflammatory Biologics Market Outlook
LIST OF CHARTS
Neuropathic Pain Treatment Paradigm
Postoperative Pain Management
OA Pain Treatment
Global Pharmaceutical Market (2003-2011)
Global Pain Management Market Size (2010 & 2011)
Global Pain Management Market Share by Country (2011)
The US Opioid Market (2007-2011)
The US Acute Pain Market Share of Therapeutic Opioids (2010)
The US Chronic Pain Market Share of Opioids (2010)
China’s NSAID Market Size (2006-2010)
NSAID Product Market Share in China (2010)
China’s Steroid Market Size (2006-2010)
Steroid Product Market Share in China (2010)
Italy’s Pain Management Market by Revenue (March 2010-March-2012)
Italy’s Pain Management Market by Unit (March 2010-March-2012)
Italy’s Pain Management Market Share by Revenue (June-2009-March-2012)
Italy’s Pain Management Market Share by Units (June-2009-March-2012)
Revenue Contribution of FANS and Opioids in Italy’s Pain Management Market (March 2010-March-2012)
Unit Contribution of FANS and Opioids in Italy’s Pain Management Market (March 2010-March-2012)
India’s Pain Management Market Share (Q4FY10-Q2FY12)
Global Spending on Medicines (2006-2016)
Global Spending on Medicine Share by Region (2006-2016)
The US Spending on Medicine (2007-2016)
Japan’s Spending on Medicine (2007-2016)
Global Ageing Population (+60 years) (2005-2013)
Global Healthcare Spending (2005-2015)
World Gross National Income (2005-2010)
Pain Management Market Share by Company (2011)
Pfizer’s Revenue Share by Business Segments (2011)
Pfizer’s Revenues & Net Income (2008-2011)
Eli Lilly’s Revenue Share by Business Segment (2011)
Eli Lilly’s Revenues and Net Income (2008-2011)
Novartis’ Revenue Share by Business Segments (2011)
Novartis’ Revenues and Net Income (2007-2011)
Johnson & Johnson’s Revenue Share by Business Segments (2011)
Johnson & Johnson’s Revenues and Net Earnings (2008-2011)
The US Anti-inflammatory Biologics Market Opportunity (2012-2015)
Outside US Anti-inflammatory Biologics Market Opportunity (2012-2015)
Ofirmev Market Opportunity (2012-2018)
Neuropathic Pain Treatment Paradigm
Postoperative Pain Management
OA Pain Treatment
Global Pharmaceutical Market (2003-2011)
Global Pain Management Market Size (2010 & 2011)
Global Pain Management Market Share by Country (2011)
The US Opioid Market (2007-2011)
The US Acute Pain Market Share of Therapeutic Opioids (2010)
The US Chronic Pain Market Share of Opioids (2010)
China’s NSAID Market Size (2006-2010)
NSAID Product Market Share in China (2010)
China’s Steroid Market Size (2006-2010)
Steroid Product Market Share in China (2010)
Italy’s Pain Management Market by Revenue (March 2010-March-2012)
Italy’s Pain Management Market by Unit (March 2010-March-2012)
Italy’s Pain Management Market Share by Revenue (June-2009-March-2012)
Italy’s Pain Management Market Share by Units (June-2009-March-2012)
Revenue Contribution of FANS and Opioids in Italy’s Pain Management Market (March 2010-March-2012)
Unit Contribution of FANS and Opioids in Italy’s Pain Management Market (March 2010-March-2012)
India’s Pain Management Market Share (Q4FY10-Q2FY12)
Global Spending on Medicines (2006-2016)
Global Spending on Medicine Share by Region (2006-2016)
The US Spending on Medicine (2007-2016)
Japan’s Spending on Medicine (2007-2016)
Global Ageing Population (+60 years) (2005-2013)
Global Healthcare Spending (2005-2015)
World Gross National Income (2005-2010)
Pain Management Market Share by Company (2011)
Pfizer’s Revenue Share by Business Segments (2011)
Pfizer’s Revenues & Net Income (2008-2011)
Eli Lilly’s Revenue Share by Business Segment (2011)
Eli Lilly’s Revenues and Net Income (2008-2011)
Novartis’ Revenue Share by Business Segments (2011)
Novartis’ Revenues and Net Income (2007-2011)
Johnson & Johnson’s Revenue Share by Business Segments (2011)
Johnson & Johnson’s Revenues and Net Earnings (2008-2011)
The US Anti-inflammatory Biologics Market Opportunity (2012-2015)
Outside US Anti-inflammatory Biologics Market Opportunity (2012-2015)
Ofirmev Market Opportunity (2012-2018)
LIST OF TABLES
Topical NSAIDs
Post Operative Pain Medications
Pain Management Drugs and Biologics Phase II Development
MOXDUO Product Portfolio Development
Nuvo’s Expanding Product Pipeline
Global Availability of NMEs (2011)
Patients Worldwide Waiting for Better Treatment Options (2011)
Competitive Landscape of Pain Therapeutics
Comparison of Pennsaid and Voltaren
Topically Applied Anesthetic Products
Estimated U.S. Anti-Inflammatory Biologics Market Buildup (2010-2015)
Estimated Ex-U.S. Anti-Inflammatory Market Buildup (2010-2015)
Ofirmev Market Opportunity Model (2012-2018)
Topical NSAIDs
Post Operative Pain Medications
Pain Management Drugs and Biologics Phase II Development
MOXDUO Product Portfolio Development
Nuvo’s Expanding Product Pipeline
Global Availability of NMEs (2011)
Patients Worldwide Waiting for Better Treatment Options (2011)
Competitive Landscape of Pain Therapeutics
Comparison of Pennsaid and Voltaren
Topically Applied Anesthetic Products
Estimated U.S. Anti-Inflammatory Biologics Market Buildup (2010-2015)
Estimated Ex-U.S. Anti-Inflammatory Market Buildup (2010-2015)
Ofirmev Market Opportunity Model (2012-2018)
